Oval Park Capital is a seed-stage hardtech venture capital firm founded in 2018 and based in Raleigh, North Carolina. The firm focuses exclusively on engineering-led startups commercializing physical and industrial technologies with defensible IP in mission-critical sectors. Oval Park invests across advanced manufacturing, advanced materials, AI infrastructure, built environment, climate and environmental technologies, defense and national security, energy, and precision agriculture. The firm takes an "early and active" approach, leading seed rounds and taking board seats to support founders through capital-efficient growth. After deploying initial capital via SPVs in 2019, Oval Park closed Venture Fund I in 2021 and Opportunity Fund I in 2023 for follow-on investments through Series A and B. The firm launched Venture Fund II in 2026. Portfolio companies include Lemurian Labs (AI infrastructure), Extellis (satellite imagery), Targan (acquired by Merck Animal Health in 2026), Emrgy (hydropower), and Grubbly Farms (insect-based agriculture).

Profile auto-generated from public sources — details unverified.